Uncoupling nNOS-PSD-95 in the ACC can inhibit contextual fear generalization

A typical feature of the contextual fear memory is increased fear generalization with time. Though much attention has been given to the neural structures that underlie the long-term consolidation of a contextual fear memory, the molecular mechanisms regulating fear generalization remain unclear. We...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2019-05, Vol.513 (1), p.248-254
Hauptverfasser: Qin, Cheng, Bian, Xin-Lan, Cai, Cheng-Yun, Chen, Chen, Zhou, Ying, Lin, Yu-Hui, Tao, Yan, Wu, Hai-Yin, Chang, Lei, Luo, Chun-Xia, Zhu, Dong-Ya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A typical feature of the contextual fear memory is increased fear generalization with time. Though much attention has been given to the neural structures that underlie the long-term consolidation of a contextual fear memory, the molecular mechanisms regulating fear generalization remain unclear. We observed that retrieval of contextual fear in a novel context at a remote time point increased coupling of neuronal nitric oxide synthase (nNOS) with postsynaptic density-95 (PSD-95) and c-Fos expression in the anterior cingulate cortex (ACC). Disrupting nNOS-PSD-95 coupling in the ACC decreased the expression of Histone deacetylase 2 (HDAC2), and inhibited contextual fear generalization at a remote time point. Together, our findings reveal nNOS-PSD-95 interaction in the ACC could be a promising target to prevent or reverse contextual fear generalization. •Contextual fear generalization up-regulated nNOS-PSD-95 coupling and HDAC2 expression.•Uncoupling nNOS-PSD-95 in the ACC inhibited fear generalization and reduced HDAC2 expression.•Knocking down the HDAC2 expression in the ACC could inhibit fear generalization.•nNOS-PSD-95 coupling could be a valuable target for the treatment of PTSD.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2019.03.184